Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein
Open Access
- 1 September 1996
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 74 (5) , 677-682
- https://doi.org/10.1038/bjc.1996.421
Abstract
The effects of several members of the family of lamellarins, polyaromatic alkaloids isolated from tunicates belonging to the genus Didemnum, on the growth of several tumour cell lines and on P-glycoprotein (P-gp)-mediated multidrug resistance (MDR), were investigated. Cytotoxicity experiments of lamellarins were performed on a panel of tumour cell lines, including two multidrug-resistant cell lines. Some lamellarins showed good anti-tumour activity, with similar levels of cytotoxicity against both the resistant and their corresponding parental cell lines. Two lamellarins displayed a high potency against lung carcinoma cells. Studies of the resistance modifier activity of the different lamellarins at non-toxic concentrations were also carried out in cells exhibiting MDR, and lamellarin I was selected for the highest chemosensitising activity. At non-toxic doses, verapamil and lamellarin I effectively increased the cytotoxicity of doxorubicin, vinblastine and daunorubicin in a concentration-dependent manner in multidrug-resistant cells, but the potency of lamellarin I as a MDR modulator was 9- to 16-fold higher than that of verapamil. In vitro measurements of rhodamine 123 accumulation in the multidrug-resistant Lo Vo/Dx cells suggest that lamellarin I reverses MDR by directly inhibiting the P-gp-mediated drug efflux. This work underscores the possibility of using these marine-derived compounds as a potential new source of anti-tumoral drugs active on resistant cells as well as of non-toxic modulators of the MDR phenotype.Keywords
This publication has 32 references indexed in Scilit:
- Chemosensitization and drug accumulation assays as complementary methods for the screening of multidrug resistance reversal agentsCancer Letters, 1996
- P-glycoprotein and Tumor ProgressionJNCI Journal of the National Cancer Institute, 1994
- A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypesEuropean Journal Of Cancer, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivativesAnti-Cancer Drugs, 1993
- Restoration of Taxol Sensitivity of Multidrug-Resistant Cells by the Cyclosporine SDZ PSC 833 and the Cyclopeptolide SDZ 280-446JNCI Journal of the National Cancer Institute, 1993
- SDZ PSC 833 and SDZ 280–446 are the most active of various resistance-modifying agents in restoring rhodamine-123 retention within multidrug resistant P388 cellsAnti-Cancer Drugs, 1992
- Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin AEuropean Journal of Cancer and Clinical Oncology, 1991
- Systemic Toxic Effects Associated With High-Dose Verapamil Infusion and Chemotherapy AdministrationJNCI Journal of the National Cancer Institute, 1991
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985